Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28187617 | 1.00 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL11520330 | 1.00 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL28119471 | 1.00 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL11397721 | 0.96 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL28193571 | 0.92 | MEN1 (0.52) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL36394 | 0.92 | TSHR (0.54) | MEN1KMT2ATHRBHTTMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL29183839 | 0.91 | MEN1 (0.55) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL27903261 | 0.89 | MEN1 (0.58) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL19032526 | 0.89 | TSHR (0.52) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL4813182 | 0.88 | TSHR (0.56) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150284350-A1 | VINYLIDENE DIMER DERIVATIVES | SHELL OIL COMPANY | 2015-10-08 | — | — | US | disclosed |
| US-20150284350-A1 | VINYLIDENE DIMER DERIVATIVES | SHELL OIL COMPANY | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284350-A1 | VINYLIDENE DIMER DERIVATIVES | MVD, PPOX, VKORC1 | MEN1 4562/4885KMT2A 2173/4885THRB 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.